In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Balchem (BCPC – Research Report), with a price target of $164.00. The company’s shares closed yesterday at $131.82.
According to TipRanks, Selvaraju is an analyst with an average return of -31.0% and a 19.54% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Regulus, Enlivex Therapeutics, and Brainsway.
Balchem has an analyst consensus of Moderate Buy, with a price target consensus of $164.00.
The company has a one-year high of $173.80 and a one-year low of $110.15. Currently, Balchem has an average volume of 110.2K.
Based on the recent corporate insider activity of 35 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in New Hampton, NY.
Read More on BCPC:
- Needham Keeps Their Buy Rating on Veeva Systems (VEEV)
- H.C. Wainwright Initiates a Buy Rating on BIGG Digital Assets (BBKCF)
- Evelo Biosciences to Participate in Morgan Stanley 20th Annual Global Health Care Conference
- First Quantum Announces Senior Leadership Appointments
- Smart Share Global Limited to Report Second Quarter 2022 Results on September 8, 2022